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Abstract 
The aim of this study is to review the clinical potential of spectroscopic X-ray detectors and to undertake a feasibility study 
using a novel detector in a clinical hospital setting. Detectors currently in development, such as Medipix-3, will have multiple 
energy thresholds allowing for routine use of spectroscopic bio-medical imaging. We have coined the term MARS (Medipix 
All Resolution System) for bio-medical images that provide spatial, temporal, and energy information. The full clinical 
significance of spectroscopic X-ray imaging is difficult to predict but insights can be gained by examining both image 
reconstruction artifacts and the current uses of dual energy techniques. This paper reviews the known uses of energy 
information in vascular imaging and mammography, clinically important fields. It then presents initial results from using 
Medipix-2, to image human tissues within a clinical radiology department. Detectors currently in development, such as 
Medipix-3, will have multiple energy thresholds allowing for routine use of spectroscopic bio-medical imaging in the future. 
© 2001 Elsevier Science. All rights reserved 
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1. Aim 
The goal of this paper is to review the benefits of 
spectroscopic X-ray detectors for bio-medical imaging. 
Images obtained with the Medipix-2 detector are used to 
establish the practicality of using such detectors within 
clinical radiology departments.  
Advances in detector technology are likely to make 
routine spectroscopic X-ray imaging possible. The growing 
use of dual energy systems is hastening the identification of 
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2. Background 
In recent years there has been a new breed of X-ray 
detectors in which the X-ray photons are processed and 
counted as individual quanta. This allows for low noise 
imaging, and extraction of energy information from the X-
ray beam. Many names are used for this type of detector, 
but common terms include: direct detector, quantum 
detector, photon counting detector and photon processing 
detector. Many of these detectors, such as Medipix-2, 
allow thresholds to be selected so that only photons within 
a specified energy range are recorded [1,2]. New detectors 
in development, such as Medipix-3, have multiple 
thresholds and counters within each pixel and thus allows 
for full spectroscopic imaging [3,4]. 
Previous work on the Medipix-2 detector has shown it 
has many of the necessary characteristics for bio-medical 
imaging, such as spatial and temporal resolution (frame rate 
for 2D imaging) [5,6]. The Medipix-2 detector is a 14mm 
square detector with 55µm square pixels [1,2]. It comprises 
a sensor layer, typically 300µm of silicon, bump bonded 
onto the CMOS micro-electronics layer. Each photon 
interacting with the sensor layer produces several electron-
hole pairs. This charge is collected and analyzed by the 
associated pixel’s electronics with each pixel working 
independently.  
The energy resolving capability of the Medipix-2 
detector is made possible by placing discriminators before 
the counting circuitry. That is, a pixel only counts an event 
if the energy of the incoming photon is between low and 
high thresholds. These thresholds are set by the user and 
can be calibrated to the energy of incident photons. Thus, it 
is possible to only count photons within a desired energy 
range, eg. 15-20 KeV. One issue with the Medipix-2 design 
is charge sharing. When charge from a single photon is 
collected by two neighboring pixels, each records separate 
events of lower energy. The Medipix-3 design corrects for 
this by summing the charge for neighboring pixels when 
co-incident events occur. The sum of the charges is then 
allocated to the pixel which recorded the highest energy [3]  
Medipix detectors are an advance because they allow for 
spectroscopic X-ray imaging, rather than simple grey scale 
imaging. Traditional spectrographs (ie. multi-channels 
analyzers) for X-ray are a “single” large pixel of up to 
several centimeters with excellent energy resolution. 
However in one proposed configuration Medipix-3 allows 
for 110µm pixels with up to eight separate energy 
thresholds [4]. Thus, the traditional approach of describing 
radiographs (X-ray images) by their spatial resolution and 
temporal resolution is no longer adequate. Rather, images 
taken with spectroscopic imaging detectors provide energy 
resolution as well as spatial and temporal resolution. We 
have coined the term MARS image (Medipix All 
Resolution System) for such spectroscopic images. 
3. Potential benefits of spectral imaging 
The full clinical significance of spectroscopic X-ray 
detectors is difficult to predict but insights can be gained by 
examining both image reconstruction artefacts caused by 
beam hardening, and the current uses of dual energy 
techniques in bio-medical imaging. 
3.1. Improved image quality 
Beam hardening artifact is a computed tomography (CT) 
artifact where an area of low attenuation is falsely 
computed around a highly attenuating object. As the X-ray 
beam passes through a highly attenuating object the lower 
energy photons are preferentially absorbed hardening the 
X-ray beam. Adjacent to the object this hardened beam is 
more penetrating (less attenuated) and so this part of the CT 
image is displayed as if it was a less attenuating material. 
The artifact is normally corrected for by either filtering the 
       
Fig. 1:  A typical triple phase CT series of the kidneys. Using traditional techniques the left image is acquired before intravenous iodinated
contrast is given, the middle image is acquired 30 seconds after administration of the contrast, and the right image 15 minutes later.
Typically the patient goes back to the waiting room during this period and it is extremely difficult to get the patient to return to exactly the
same position within the scanner. Thus a traditional scan requires 3 acquisitions, and two visits to the scanner. Using a spectroscopic
detector with a combination of gadolinium and iodine contrast agents the three images could be obtained with a single scan, reducing the
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beam at the source, or by advanced software algorithms [7]. 
Neither technique completely suppresses the artefact. 
In clinical medicine beam hardening artifact remains an 
important issue. The artifact is common around metal 
implants such as joint replacements, catheters, and vascular 
stents. Unfortunately, by the very nature of these implants, 
the artifact often obscures the areas of clinical concern 
making it difficult to confidently diagnose or exclude 
infections, tumours, or fractures close to implants [8,9]. 
3.2. K-edge imaging 
Most CT studies use contrast agents such as chelated 
gadolinium or iodine [10-12]. These agents are used for 
vascular studies, tumor characterization studies, and variety 
of other applications. Both agents have K-edges within the 
diagnostic X-ray energy range, 33 KeV and 50 KeV 
respectively. 
The sharp edge in the attenuation profile has allowed 
development of dual energy X-ray systems where two 
different images are acquired with different energy X-ray 
sources [13]. A difference image is then used to identify the 
contrast agent separate from background structures. That is, 
it would be possible to separate calcium in renal stones 
from iodinated contrast in the renal parenchyma. In 
addition K-edge imaging can be used to identify contrast 
agents which have been injected with lower concentrations 
of iodine and gadolinium than current used. Thus, the same 
or better image quality could be achieved more safely and 
at a lower cost 
Using spectroscopic detectors (more than two energies), 
rather than dual sources, it is also possible to separate these 
contrast agents from background structures. Furthermore, 
with spectroscopic detectors it is possible to identify 
background structures, gadolinium, and iodine as three 
separate components.  Simulations have confirmed that this 
is possible for both 2-dimensional and 3-dimensional (CT) 
images [14,15]. 
The availability of routine spectroscopic imaging will 
decrease patient examination time at substantially reduced 
radiation dose, allowing improved safety and greater 
productivity. This is particularly significant in multi-phase 
protocols where images are typically acquired before iodine 
contrast, immediately following injection, and 15 minutes 
after injection [11,12]. Figure 1 contains an example of a 
conventional CT triple phase renal protocol. With a MARS 
imaging system these three images can be obtained with a 
single scan. This could be achieved by giving iodine 
contrast intravenously 15 minutes before scanning, then 
gadolinium 30 seconds before scanning. The three different 
images could then be calculated by subtracting off the 
gadolinium, then iodine, then both agents without the need 
for additional scanning. 
Other advantages in using a single exposure with a 
spectroscopic detector, rather than dual energy sources, 
include no patient movement between images, a single 
source of quantum (Poisson) noise, and no overlapping 
spectra. 
3.3. Intrinsic tissue contrast. 
It is well known that many tissues have different 
attenuation profiles. Again, this is the basis of dual energy 
X-ray absorption techniques such as bone densitometry and 
dual energy chest radiography [11,12]. The underlying 
physical principle is that atoms within a mixture each have 
a different X-ray attenuation profile which depends on the 
atom’s proton number and electron configuration [16]. 
A short review of the literature shows there are many 
areas where energy information will be of clinical benefit. 
However, dose and other practical considerations limit 
routine use of dual source systems. 
To estimate the magnitude of the benefit from 
spectroscopic images, it is helpful to review the literature 
regarding mammography, an area of clinical significance 
and public interest. There are a number of studies that have 
examined the use of dual energy systems at improving 
        
Fig. 2:  The left image is a photograph of an excised breast lesion containing normal tissue and a ductal carcinoma. The middle image is a
radiograph of the specimen taken using conventional mammographic film. The right radiograph is taken by tiling images from a Medipix-2
detector. In both the film and Medipix images the typical features of the cancer are clearly seen. Namely, a central density with radiating spicules.
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detection of cancerous and pre-cancerous lesions. 
Important benefits include: 
• Microcalcification detection: Pre-malignant areas in a 
breast, such as ductal carcinoma in-situ, often contain 
micro-calcifications. These are an important feature used 
for mammographic screening of breast cancer. 
Unfortunately due to their extremely small size they can be 
difficult to identify. Several studies have shown that an 
energy resolving system increases the ability of the 
radiologist to identify these microcalcifications [17]. 
• Distinguishing tissues types: Currently clinicians use 
morphological information to distinguish normal from 
abnormal tissues. For example, to distinguish fibrous tissue 
from malignant tissue a radiologist may use size and the 
presence of spicules radiating away from the lesion. 
However it is known that fibrous tissue and malignant 
tissue have different attenuation profiles [18,19]. Clinical 
trials with dual energy sources report that 62% of cancers 
and 81% of benign masses can be more accurately 
identified [20]. 
• Tumors retain intravenously injected iodinated contrast 
agents. This physiological characteristic is the basis for 
dual energy contrast mammography and MRI breast 
imaging [11,12,21]. 
The spectroscopic detector with a MARS system will 
allow routine use of energy resolving imaging. This is 
because there is no time or dose penalty to recording the 
energy response of the tissue, whereas dual source systems 
require higher dosage, often more time in  image 
acquisition, and they introduce movement problems 
between images. 
4. Imaging of biological samples 
In order to demonstrate that the Medipix-2 detector can 
produce clinical images we undertook a program of using 
the detector in a hospital to image human samples. Initially 
2 and 3 dimensional images were obtained with the high 
and low energy thresholds as far apart as possible in order 
to produce images in which all energies contribute, similar 
to non-spectroscopic images. Subsequently 2-dimensional 
images were obtained where a series of different thresholds 
were used, producing a 2-dimensional spectroscopic image. 
4.1. 2-dimensional images 
Previous work has shown that the spatial resolution and 
contr st resolution of Medipix-2 is adequate to produce 
diagnostic mammography images [5,6]. However most of 
this work was done with phantoms and little work has been 
published imaging real human breast disease.  
We imaged a series of 7 excised breast specimens using 
both a Medipix-2 detector and traditional mammographic 
film. Each specimen contained a known breast lesion, 
typically a cancer, that had been identified during routine 
clinical work and then removed by a surgeon. Sub-images 
from the Medipix-2 detector were tiled together in software 
to produce a single larger image that covered the entire 
lesion. Each image was reviewed by a clinical radiologist to 
ensure that the Medipix image contained all radiologically 
important details that were present in the plain film image.  
An example of a ductal carcinoma (sub-type NOS) is 
shown in figure 2. This work confirmed the pre-clinical 
studies that showed Medipix-2 produces similar image 
quality to mammographic film. 
4.2. 3 dimensional images 
Any imaging system that can produce 2-dimensional 
images can be adapted to produce projection images for 
CT. Our goal was to use a Medipix-2 detector to produce 
CT images of human tissue. Again, the thresholds were 
wide in order to produce data similar to non-spectroscopic 
detectors.  
       
Fig. 3:  Images of a 12mm finger bone from a dried human skeleton. The left image is one of the 180 projection images used to
reconstruct the volume data. The hole in the shaft is where a wire articulated the bone with the remainder of the dried skeleton. The
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For the experiment, the distal phalynx from the 5th finger 
of a dried human skeleton was attached to the end of a 
stepper motor. 180 projection images were obtained at 1o 
angles. The geometry was with a source-detector distance 
of 1m, and the center of rotation to detector of 1cm. This 
set up provided parallel beam geometry, with the maximum 
irradiation angle 0.3°. Reconstruction was performed using 
a filtered back projection algorithm. Figure 3 shows one of 
the projection images and two cross sectional images after 
reconstructing the projections into a volume data set.  
4.3. Spectroscopic images 
The final step was to image human tissues with a range 
of narrow energy thresholds in order to produce 
spectroscopic images. Using this technique images of the 
hand from a miscarried 20 week human fetus were 
obtained. 
Seven energy windows were chosen, evenly spaced 
between 4 KeV (the detector’s noise floor) and 27 KeV (the 
X-ray tube voltage). Principal Components Analysis (PCA) 
was then applied to the spectral data to identify patterns of 
independent variance [22]. The first three components 
identified and are shown in figure 4. Three dead columns in 
the detector were filled using bi-cubic interpolation. 
Using this method the bone and soft tissues could be 
identified, despite the semi-ossified nature of early fetal 
bone development. This is in keeping with results from 
dual source radiography where the energy information is 
used to calculate bone density [11,12]. In addition the PCA 
process identified a line along the dead column and the 
bottom of the detector in which the detector energy 
response varied from the rest of the detector.  
5. Conclusion 
The anticipated benefits from using spectroscopic pixel 
detectors for bio-medical imaging include reduction of 
image artifacts, better contrast imaging, and improved soft 
tissue contrast. 
Initial work with the Medipix-2 detector found that is a 
reliable and easy to use device. Importantly it is robust 
enough for further clinical work. Our experiments using 
human tissues have confirmed other groups’ work with 
phantoms that Medipix-2 can produce images of at least the 
quality of conventional radiographic films. 
6. Future Work 
An important future development will be the availability 
of Medipix-3 detectors. These detectors will be able to be 
configured to have eight energy thresholds per pixel, thus 
allowing a single exposure to record eight different energy 
ranges. 
The design of both the Medipix-2 and Medipix-3 
detectors allow for materials other than silicon to be used as 
the sensor layer. Use of other materials, such as gallium 
arsenide, will give a detector with excellent quantum 
efficiency at the X-ray energies typically used in clinical 
medicine [23].  
While a brief literature review has allowed identification 
of several pathologies where energy information is useful, 
it will be necessary to explore a wider range of diseases to 
assess the full clinical benefit of this new technology. 
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